The document outlines the corporate communication strategies of a leading pharmaceutical company focused on immunosuppressants, including objectives for public relations, a planned media campaign, and initiatives to engage with the transplant community. Key topics include budget constraints, crisis management surrounding high drug costs, and lobbying efforts for amendments to the human organ donation act. Additionally, it discusses the importance of pre-IPO communication to generate media interest and retain customers.
Related topics: